Changes in CA125
LogCA125 significantly decreased in patients on treatment with dapagliflozin [1-month: Δ − 0.18, (CI 95% = − 0.33 to − 0.22; p = 0.025), and 3-month: Δ − 0.23, (CI 95% = − 0.38 to − 0.07; p-value = 0.005), omnibus p-value = 0.012] as is shown in Fig. Changes in logCA125 (After adjusting for post-treatment confounding by hemoglobin and pre-treatment values of peakVO